Expansion of standard manufacturing rules on drugs, etc. eyed

Published: 2003-04-30 07:00:00

Updated: 2003-04-30 07:00:00

The Korea Food and Drug Administration said it would expand the scope of the standard manufacturing rules on drugs, etc. as part of measures to promote over-counter-drugs (OTCs) in the domestic pharmaceutical industry, while ensuring better financial stability in the national health insurance sch...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK